BIOTIME INC DEF 14A 7-10-2015

Company

Lineage Cell Therapeutics, Inc.

Filed

June 11, 2015

Period of Report

July 10, 2015

Accession Number

0001140361-15-023977

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →